Over the Counter Medications, Brand Names Beginning with ‘G’

Page 1 of 306 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

G and H Protect Body (ENSULIZOLE, OCTISALATE, ZINC OXIDE)

Helps prevent sunburn. Warnings: For external use only. Do not use on broken or damaged skin. When using this product: kep out of eyes. Rinse with water to remove. Stop use and ask a…

Access Business Group LLC23 October 2023

G and H Protect Hand (BENZALKONIUM CHLORIDE)

Helps reduce bacteria on hands. Warnings: For external use only. When using this product: avoid contact with eyes. In case of contact, rinse thoroughly with water. Stop use and ask a…

Access Business Group LLC23 October 2023

G and H Protect Hand Sanitizer (ALCOHOL)

Hand sanitizer to help reduce bacteria on the skin that potentially can cause disease. For use when soap and water are not available. Warnings: For external use only. Flammable. Keep away…

Access Business Group LLC23 October 2023

G and H Protect Plus Advanced Hand Sanitizer (ALCOHOL)

Hand sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available. Warnings: For external use only. Flammable. Keep away from heat…

Access Business Group LLC23 October 2023

G AND Y ANTIBACTERIAL HAND WIPES (Benzalkonium Chloride)

For handwashing to decrease bacteria on the skin. Warning: For external use only. Do not use, in the eyes. if you are allergic to any of the ingredients. When using this product: if eye…

ERUSLU SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI14 May 2020

Page 1 of 306 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Antiseizure Medicines Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam): Drug Safety Communication – FDA Warns of Rare but Serious Drug Reaction
Mon, 27 Nov 2023. The FDA is warning that the antiseizure medicines can cause a rare but serious reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), that can be life-threatening if not diagnosed and treated quickly.
BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies: FDA Safety Communication – FDA Investigating Serious Risk of T-cell Malignancy
Mon, 27 Nov 2023. The FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.

OTCLabels

Medication Sections

Medication Information by RSS

About

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.